MAP3K19
| Official symbol: | MAP3K19 |
| Full name: | mitogen-activated protein kinase kinase kinase 19 |
| Location: | 2q21.3 |
| Also known as: | FLJ23074, YSK4, RCK |
| Entrez ID: | 80122 |
| Ensembl ID: | ENSG00000176601 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 1 |
|
|
| Fusions detected in 1 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 1.74 (Percentile rank: 15.48%) |
| PubTator score: | 52.39 (Percentile rank: 68.69%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
